Mohan Babu Appaiahgari

689 total citations
18 papers, 516 citations indexed

About

Mohan Babu Appaiahgari is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Mohan Babu Appaiahgari has authored 18 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Public Health, Environmental and Occupational Health and 4 papers in Molecular Biology. Recurrent topics in Mohan Babu Appaiahgari's work include Mosquito-borne diseases and control (8 papers), Viral Infections and Vectors (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Mohan Babu Appaiahgari is often cited by papers focused on Mosquito-borne diseases and control (8 papers), Viral Infections and Vectors (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Mohan Babu Appaiahgari collaborates with scholars based in India, United States and Saudi Arabia. Mohan Babu Appaiahgari's co-authors include Sudhanshu Vrati, Sudhanshu Vrati, Sunita Taneja, Shakti Singh, Nita Bhandari, Temsunaro Rongsen‐Chandola, Jyoti Jyoti, Manisha Saini, R. M. Pandey and Roger I. Glass and has published in prestigious journals such as The Journal of Infectious Diseases, Vaccine and Molecular Therapy.

In The Last Decade

Mohan Babu Appaiahgari

17 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohan Babu Appaiahgari India 12 357 179 114 94 89 18 516
Luwanika Mlera United States 15 377 1.1× 229 1.3× 86 0.8× 17 0.2× 80 0.9× 24 547
Britt Åkerlind Sweden 12 307 0.9× 77 0.4× 40 0.4× 81 0.9× 298 3.3× 21 640
Elena A. Prikhod’ko United States 10 151 0.4× 86 0.5× 226 2.0× 84 0.9× 169 1.9× 11 528
Yukie Shimazu Japan 14 342 1.0× 102 0.6× 85 0.7× 97 1.0× 354 4.0× 36 632
Michelle Walker United States 13 302 0.8× 133 0.7× 150 1.3× 31 0.3× 285 3.2× 16 616
Shaoli Lin China 16 318 0.9× 58 0.3× 94 0.8× 135 1.4× 78 0.9× 36 610
Philippe Pérot France 14 272 0.8× 37 0.2× 134 1.2× 121 1.3× 92 1.0× 29 574
Jalal Nourlil Morocco 11 211 0.6× 57 0.3× 42 0.4× 69 0.7× 102 1.1× 22 404
Kazuo Miyazaki Japan 11 244 0.7× 58 0.3× 57 0.5× 58 0.6× 124 1.4× 28 385
Yogesh A. Karpe India 14 265 0.7× 94 0.5× 118 1.0× 19 0.2× 96 1.1× 17 541

Countries citing papers authored by Mohan Babu Appaiahgari

Since Specialization
Citations

This map shows the geographic impact of Mohan Babu Appaiahgari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohan Babu Appaiahgari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohan Babu Appaiahgari more than expected).

Fields of papers citing papers by Mohan Babu Appaiahgari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohan Babu Appaiahgari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohan Babu Appaiahgari. The network helps show where Mohan Babu Appaiahgari may publish in the future.

Co-authorship network of co-authors of Mohan Babu Appaiahgari

This figure shows the co-authorship network connecting the top 25 collaborators of Mohan Babu Appaiahgari. A scholar is included among the top collaborators of Mohan Babu Appaiahgari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohan Babu Appaiahgari. Mohan Babu Appaiahgari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ishani, Areef, Sudhanshu Vrati, Mohammad Khalid Parvez, et al.. (2025). Psoralidin acts as a dual protease inhibitor against PL pro and M pro of SARS ‐ CoV ‐2. FEBS Journal. 292(5). 1106–1123. 1 indexed citations
2.
Kumar, Vikas, Rajiv K. Singh, Shivajirao L. Gholap, et al.. (2025). Ethyl acetate extract of Ruta graveolens: a specific and potent inhibitor against the drug-resistant EGFR_T790M mutant in NSCLC. Frontiers in Pharmacology. 16. 1570108–1570108. 1 indexed citations
3.
Singh, Deepa, Vikas Kumar, Manoj Kumar, et al.. (2025). Redefining NSP12 activity in SARS-CoV-2 and its regulation by NSP8 and NSP7. Molecular Therapy — Nucleic Acids. 36(1). 102452–102452.
4.
Inampudi, Krishna Kishore, et al.. (2023). Identification of a novel inhibitor of SARS‐CoV ‐2 main protease: an in silico , biochemical, and cell‐based approach. FEBS Journal. 290(23). 5496–5513. 5 indexed citations
5.
Appaiahgari, Mohan Babu & Sudhanshu Vrati. (2014). Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls. Expert Opinion on Biological Therapy. 15(3). 337–351. 76 indexed citations
6.
Appaiahgari, Mohan Babu, Roger I. Glass, Shakti Singh, et al.. (2013). Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine. 32(6). 651–656. 60 indexed citations
7.
Chandola, Tarani, Sunita Taneja, Nidhi Goyal, et al.. (2013). Descriptive epidemiology of rotavirus infection in a community in North India. Epidemiology and Infection. 141(10). 2094–2100. 10 indexed citations
8.
Appaiahgari, Mohan Babu & Sudhanshu Vrati. (2012). Clinical development of IMOJEV®—a recombinant Japanese encephalitis chimeric vaccine (JE-CV). Expert Opinion on Biological Therapy. 12(9). 1251–1263. 30 indexed citations
9.
Appaiahgari, Mohan Babu & Sudhanshu Vrati. (2010). IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine. Expert Review of Vaccines. 9(12). 1371–1384. 51 indexed citations
10.
Bhandari, Nita, Pooja Sharma, Sunita Taneja, et al.. (2009). A Dose‐Escalation Safety and Immunogenicity Study of Live Attenuated Oral Rotavirus Vaccine 116E in Infants: A Randomized, Double‐Blind, Placebo‐Controlled Trial. The Journal of Infectious Diseases. 200(3). 421–429. 58 indexed citations
11.
Appaiahgari, Mohan Babu, Malik Zainul Abdin, K. C. Bansal, & Sudhanshu Vrati. (2009). Expression of Japanese encephalitis virus envelope protein in transgenic tobacco plants. Journal of Virological Methods. 162(1-2). 22–29. 9 indexed citations
12.
Appaiahgari, Mohan Babu & Sudhanshu Vrati. (2007). DNAzyme-mediated Inhibition of Japanese Encephalitis Virus Replication in Mouse Brain. Molecular Therapy. 15(9). 1593–1599. 44 indexed citations
13.
Appaiahgari, Mohan Babu, R. M. Pandey, & Sudhanshu Vrati. (2007). Seroprevalence of Neutralizing Antibodies to Adenovirus Type 5 among Children in India: Implications for Recombinant Adenovirus-Based Vaccines. Clinical and Vaccine Immunology. 14(8). 1053–1055. 28 indexed citations
14.
15.
Appaiahgari, Mohan Babu, et al.. (2005). Effect of Cytokine‐Encoding Plasmid Delivery on Immune Response to Japanese Encephalitis Virus DNA Vaccine in Mice. Microbiology and Immunology. 49(4). 349–353. 16 indexed citations
16.
Kaur, Rupinderjeet, et al.. (2004). Oral immunization of mice with Japanese encephalitis virus envelope protein synthesized in Escherichia coli induces anti-viral antibodies. Microbes and Infection. 6(14). 1305–1311. 17 indexed citations
17.
Appaiahgari, Mohan Babu & Sudhanshu Vrati. (2004). Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells. Vaccine. 22(27-28). 3669–3675. 29 indexed citations
18.
Kabilan, L, S. Ramesh, Shankar Srinivasan, et al.. (2004). Japanese encephalitis virus (JEV) is an important cause of encephalitis among children in Cuddalore district, Tamil Nadu, India. Journal of Clinical Virology. 31(2). 153–159. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luwanika Mlera Breakdown of academic impact, for papers by Britt Åkerlind Breakdown of academic impact, for papers by Elena A. Prikhod’ko Breakdown of academic impact, for papers by Yukie Shimazu Breakdown of academic impact, for papers by Michelle Walker Breakdown of academic impact, for papers by Shaoli Lin Breakdown of academic impact, for papers by Philippe Pérot Breakdown of academic impact, for papers by Jalal Nourlil Breakdown of academic impact, for papers by Kazuo Miyazaki Breakdown of academic impact, for papers by Yogesh A. Karpe
Rankless by CCL
2026